COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC:
Get the latest research information from NIH:

Coronavirus Guidance for NIH Applicants and Grantees:

Dr. Lambratu Rahman Sesay

Dr. Lambratu Rahman Sesay

Scientific Review Officer


Division of Translational and Clinical Sciences DTCS
Oncology 2 – Translational Clinical OTC
Study Section:
Mechanisms of Cancer Therapeutics - 1 Study Section MCT1

Dr. Lambratu Rahman Sesay serves as the Scientific Review Officer for the Basic Mechanism of Cancer Therapeutics Study Section within the Oncology Translational Clinical (OTC) Integrated Review Group. Dr. Rahman Sesay received her Ph.D. in biochemistry from Howard University in Washington, DC. Before coming to CSR, she was an intramural research training associate in the Molecular Therapeutics Program at the National Cancer Institute.